Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. (TMO) is a healthcare and life sciences tools and diagnostics company with $60.9M in federal contracts and a $60K lobbying spend in 2024, and holds a structural political signal from 8 politicians with aligned lobbying patterns including Sen. Susan Collins (R-ME), chair of Senate Appropriations.
BusinessWhat TMO does
Thermo Fisher Scientific provides analytical instruments, equipment, reagents, consumables, software, and services for research, analysis, discovery, and diagnostics across healthcare, life sciences, and industrial markets. Revenue lines include life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and services. The company is a significant federal contractor across 10 agencies including Defense, Health and Human Services, and Veterans Affairs.
12 months past · 3 months futureTMO activity timeline
Executive Branch ConflictsTMO held by Trump-administration officials
Lifetime Government AwardsTMO federal contracts by year
Smart Money · 13F HoldingsHedge funds holding TMO
Politicians Trading TMOMembers of Congress with recent TMO positions
Congressional TradesWho in Congress is trading TMO
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
Stock awards & option exercises
Bills Affecting TMOLive legislation impacting this stock
Political ProfileWhere TMO sits in Washington
[object Object]
STRUCTURAL: 8 politicians with lobbying patterns aligned to committees (e.g., Sen. Collins chairs Appropriations, Rep. Bresnahan on Transportation). Lobbying spend $60K on healthcare and government issues including PASTEUR Act. EVIDENTIARY: Congressional trading active (e.g., bioguide_id K000389 multiple purchases/sales). Executive branch exposure includes Trump holding common stock. Net: Strong structural alignment with key appropriations and health committees, but limited insider buying (0 corp insider buys in 180 days) and moderate contract scale ($60.9M).
Regulatory ExposureThreats & opportunities
Regulatory threats
-
Antimicrobial resistance regulation and CMS SEP-1 measure implementationCenters for Medicare & Medicaid Services (CMS), Centers for Disease Control and Prevention (CDC)"get_political_influence.lobbying_patterns[0].specific_issues cites 'CMS SEP-1 measure implementation. CDC AMR activities.'"
Regulatory opportunities
-
PASTEUR Act promoting antibiotic subscriptions and FDA cleared biomarkers for preeclampsiaFood and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC)"get_political_influence.lobbying_patterns[0].specific_issues cites 'Pioneering Antimicrobial Subscriptions to End Upsurging Resistance PASTEUR Act... issues related to health insurance coverage and re"
Capitol Hill AlliesChampions & critics
Congressional champions
Congressional critics
- No specific congressional critics identified.
LobbyingWho's hired to advocate for TMO
Live signals + predictions for TMO — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades TMO
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord